TipRanks
Go Ultimate75% OFF

American Beacon ARK Transformational Innovation Fund R6 Class (ADNRX) Forecast

See the Price Targets and Ratings of:

ADNRX Analyst Rating

Strong Buy
47ConsensusRatings
43Buy4Hold0Sell
Based on the Wall Street analyst consensus for 47 of ADNRX’s holdings.

ADNRX Analyst Price Target

$31.24▲(47.58% Upside)
Based on Wall Street analyst 12-month price targets for 47 of American Beacon ARK Transformational Innovation Fund R6 Class’s holdings in the last 3 months. The average price target is $31.24 with a high forecast of $45.29 and a low forecast of $18.49. The average price target represents a 47.58% change from the last price of $21.17.
Highest Price Target$45.29Average Price Target$31.24Lowest Price Target$18.49

ADNRX Stocks With Highest Upside Potential

ADNRX highest upside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Strong Buy$268.56
Moderate Buy$28.63
Moderate Buy$123.21
Moderate Buy$48.80
Strong Buy$10.33

ADNRX Stocks With Highest Downside Potential

ADNRX highest downside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Moderate Buy$49.47
Moderate Buy$702.18
Strong Buy$1,515.22
Moderate Buy$85.80
Moderate Buy$408.45

ADNRX Mutual Fund FAQ

What is ADNRX’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 47 of ADNRX’s holdings, American Beacon ARK Transformational Innovation Fund R6 Class’s 12-month average price target is $31.24.
What is ADNRX’s upside potential, based on the analysts’ average price target?
ADNRX’s average price target of $31.24 represents a 47.58% upside from its last price of $21.17.
Is ADNRX a Buy, Sell or Hold?
American Beacon ARK Transformational Innovation Fund R6 Class has a consensus rating of Strong Buy, based on the analyst consensus for 47 of ADNRX’s holdings: 43 rated Buy, 4 rated Hold and 0 rated Sell.
What is American Beacon ARK Transformational Innovation Fund R6 Class’s price target?
The average price target for American Beacon ARK Transformational Innovation Fund R6 Class is $31.24, based on Wall Street analyst 12-month price targets for 47 of ADNRX’s holdings, issued in the past 3 months. The highest price target is $45.29 and the lowest is $18.49. The average price target represents a 47.58% increase from the last price of $21.17.
How can I buy shares of ADNRX?
You can buy shares of ADNRX through a brokerage account. Compare brokers on our Best Online Brokers page.